Interaction of calcitonin gene related peptide (CGRP) and substance P (SP) in human skin. 2016

Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, D-55131 Mainz, Germany. Electronic address: tanja.schlereth@unimedizin-mainz.de.

Calcitonin gene related peptide (CGRP) and substance P (SP) are neuropeptides that are simultaneously released from nociceptive C-fibers. CGRP is a potent vasodilator, inducing a long-lasting increase in superficial skin blood flow, whereas SP induces only a brief vasodilation but a significant plasma extravasation. CGRP and SP may play important roles in the pathophysiology of various pain states but little is known about their interaction. Different concentrations of SP (ranging from 10-5M to 10-9M) were applied to the volar forearm of 24 healthy subjects via dermal microdialysis. SP was applied either alone or in combination with CGRP10-9M and CGRP 10-6M. As expected, SP induced a transient increase in skin blood flow that decayed shortly after application. This transient blood flow peak was blunted with co-application of CGRP 10-9M and inhibited with co-application of CGRP10-6M. SP alone induced plasma protein extravasation (PPE). However, when CGRP10-6M was added, the PPE significantly increased. Our results demonstrate a complex interaction of the neuropeptides CGRP and SP. CGRP10-6M prevented SP-induced early vasodilation but augmented SP-induced PPE. These interactions might explain why vascular symptoms in chronic pain can differ strikingly between individuals.

UI MeSH Term Description Entries
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005542 Forearm Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST. Antebrachium,Antebrachiums,Forearms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D015740 Calcitonin Gene-Related Peptide A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Calcitonin Gene-Related Peptide I,Calcitonin Gene-Related Peptide II,alpha-CGRP,alpha-Calcitonin Gene-Related Peptide,beta-CGRP,beta-Calcitonin Gene-Related Peptide,Calcitonin Gene Related Peptide,Calcitonin Gene Related Peptide I,Calcitonin Gene Related Peptide II,Gene-Related Peptide, Calcitonin,alpha Calcitonin Gene Related Peptide,beta Calcitonin Gene Related Peptide
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
January 1992, Annals of the New York Academy of Sciences,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
March 1988, Brain research,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
April 1992, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
January 2001, Autonomic neuroscience : basic & clinical,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
February 1997, The Journal of comparative neurology,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
January 2004, Pituitary,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
January 1987, International archives of allergy and applied immunology,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
Tanja Schlereth, and Jonas Schukraft, and Heidrun H Krämer-Best, and Christian Geber, and Tatiana Ackermann, and Frank Birklein
February 1994, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!